Atlas Trials

Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)

Clinical trial NCT06179407 · TERMINATED

Trial details

NCT number
NCT06179407
Sponsor
Merck Sharp & Dohme LLC
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Narcolepsy
Start date
2024-01-24
Primary completion
2024-10-23
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.